United Capital Financial Advisors’s Celgene Corp CELG Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2019
Q4 | – | Sell |
-115,643
| Closed | -$11.5M | – | 1463 |
|
|
2019
Q3 | $11.5M | Sell |
115,643
-12,512
| -10% | -$1.19M | 0.08% | 272 |
|
|
2019
Q2 | $11.8M | Buy |
128,155
+896
| +0.7% | +$85.1K | 0.08% | 269 |
|
|
2019
Q1 | $12M | Buy |
127,259
+4,926
| +4% | +$431K | 0.08% | 261 |
|
|
2018
Q4 | $7.84M | Sell |
122,333
-21,606
| -15% | -$1.59M | 0.06% | 296 |
|
|
2018
Q3 | $12.9M | Sell |
143,939
-1,680
| -1% | -$148K | 0.09% | 246 |
|
|
2018
Q2 | $11.6M | Sell |
145,619
-4,850
| -3% | -$403K | 0.09% | 274 |
|
|
2018
Q1 | $13.4M | Sell |
150,469
-46,209
| -23% | -$4.44M | 0.1% | 226 |
|
|
2017
Q4 | $20.6M | Sell |
196,678
-2,130
| -1% | -$240K | 0.16% | 147 |
|
|
2017
Q3 | $29M | Buy |
198,808
+2,502
| +1% | +$341K | 0.25% | 97 |
|
|
2017
Q2 | $25.5M | Buy |
196,306
+796
| +0.4% | +$97.5K | 0.23% | 100 |
|
|
2017
Q1 | $24.3M | Sell |
195,510
-3,391
| -2% | -$406K | 0.23% | 100 |
|
|
2016
Q4 | $23M | Buy |
198,901
+909
| +0.5% | +$101K | 0.22% | 97 |
|
|
2016
Q3 | $20.7M | Buy |
197,992
+25,947
| +15% | +$2.81M | 0.2% | 115 |
|
|
2016
Q2 | $17M | Buy |
172,045
+5,366
| +3% | +$555K | 0.17% | 131 |
|
|
2016
Q1 | $16.7M | Buy |
166,679
+8,048
| +5% | +$829K | 0.18% | 115 |
|
|
2015
Q4 | $19M | Buy |
158,631
+17,126
| +12% | +$1.98M | 0.22% | 92 |
|
|
2015
Q3 | $15.3M | Sell |
141,505
-7,005
| -5% | -$869K | 0.18% | 108 |
|
|
2015
Q2 | $17.2M | Sell |
148,510
-29,153
| -16% | -$3.33M | 0.2% | 115 |
|
|
2015
Q1 | $19.2M | Sell |
177,663
-9,706
| -5% | -$1.16M | 0.23% | 104 |
|
|
2014
Q4 | $21M | Sell |
187,369
-28,429
| -13% | -$3M | 0.31% | 82 |
|
|
2014
Q3 | $20.5M | Sell |
215,798
-35,803
| -14% | -$3.23M | 0.36% | 72 |
|
|
2014
Q2 | $21.6M | Buy |
251,601
+61,923
| +33% | +$4.71M | 0.4% | 62 |
|
|
2014
Q1 | $13.2M | Buy |
189,678
+47,218
| +33% | +$3.74M | 0.28% | 83 |
|
|
2013
Q4 | $12M | Buy |
142,460
+73,438
| +106% | +$5.81M | 0.41% | 64 |
|
|
2013
Q3 | $5.32M | Sell |
69,022
-188,336
| -73% | -$13.2M | 0.17% | 136 |
|
|
2013
Q2 | $15.1M | Buy |
+257,358
| New | +$15.5M | 0.4% | 66 |
|
Other funds holding CELG
FP
HCM
PCMC
WCG
United Capital Financial Advisors's CELG Position: Q4 2019 in Review
United Capital Financial Advisors sold out of Celgene Corp (CELG) in Q4 2019, closing a stake of 115,643 shares — an estimated $11.5M sold.
United Capital Financial Advisors first reported a position in CELG in Q2 2013 and held it in 26 quarters. The position peaked at $29M in Q3 2017. 4 funds tracked by Wall St. Rank hold CELG as of Q4 2019.
- United Capital Financial Advisors reported no remaining Celgene Corp position as of Q4 2019 after selling out during the quarter.
- United Capital Financial Advisors sold 115,643 Celgene Corp shares in Q4 2019, an estimated $11.5M.
- United Capital Financial Advisors first reported a position in Celgene Corp in Q2 2013 and held it in 26 quarters.
- United Capital Financial Advisors's Celgene Corp position peaked at $29M in Q3 2017.
- 4 funds tracked by Wall St. Rank held Celgene Corp as of Q4 2019.
Based on United Capital Financial Advisors's 13F filing for Q4 2019, filed 14 Feb 2020.